- Filed
- Apr 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 15, 2025 | 77.37M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $4.55B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.51B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $360.67M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $409.35M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.47B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.59B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.3B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.39B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.24B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.34B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.45B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 79.51M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $69.99M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $131.31M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.27M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $300.14M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$650.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$739.76M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.23 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $40.53M |
| Net Income | Q1 2025 · Mar 31, 2024 | $255.95M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $339.38M |
| Revenue | Q1 2025 · Mar 31, 2024 | $679.97M |